Canopy Growth (CGC) Net Income (QoQ) (2019 - 2024)
Canopy Growth (CGC) Net Income (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.87 Bn | 16.55 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Canopy Growth | 274.02 Mn | 8.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 59.06% |
| Jun 30, 2024 | -13.49% |
| Mar 31, 2024 | -82.48% |
| Dec 31, 2023 | 107.51% |
| Sep 30, 2023 | -465.60% |
| Jun 30, 2023 | 47.18% |
| Mar 31, 2023 | -59.51% |
| Dec 31, 2022 | 67.02% |
| Sep 30, 2022 | 94.89% |
| Jun 30, 2022 | -301.93% |
| Mar 31, 2022 | -345.49% |
| Dec 31, 2021 | -606.26% |
| Sep 30, 2021 | -104.09% |
| Jun 30, 2021 | 462.27% |
| Mar 31, 2021 | 86.23% |
| Dec 31, 2020 | -777.90% |
| Sep 30, 2020 | 21.71% |
| Jun 30, 2020 | 91.53% |
| Mar 31, 2020 | -1,215.54% |
| Dec 31, 2019 | -145.17% |